These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21806800)

  • 1. Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.
    Cruz-Aponte M; McKiernan EC; Herrera-Valdez MA
    BMC Infect Dis; 2011 Aug; 11():207. PubMed ID: 21806800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply.
    Medema JK; Zoellner YF; Ryan J; Palache AM
    Virus Res; 2004 Jul; 103(1-2):9-15. PubMed ID: 15163482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.
    Hessel L;
    Influenza Other Respir Viruses; 2009 Jul; 3(4):165-70. PubMed ID: 19627373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
    ; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
    Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate.
    Riley S; Wu JT; Leung GM
    PLoS Med; 2007 Jun; 4(6):e218. PubMed ID: 17579511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we prepared to help low-resource communities cope with a severe influenza pandemic?
    Starbuck ES; von Bernuth R; Bolles K; Koepsell J
    Influenza Other Respir Viruses; 2013 Nov; 7(6):909-13. PubMed ID: 23145978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine supply: building long-term sustainability.
    Hehme N; Colegate T; Palache B; Hessel L
    Vaccine; 2008 Sep; 26 Suppl 4():D23-6. PubMed ID: 19230154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.
    Pan Y; Wang Q; Yang P; Zhang L; Wu S; Zhang Y; Sun Y; Duan W; Ma C; Zhang M; Zhang X; MacIntyre CR
    Vaccine; 2017 Dec; 35(51):7133-7138. PubMed ID: 29128383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.
    Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB
    Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling optimal age-specific vaccination strategies against pandemic influenza.
    Lee S; Golinski M; Chowell G
    Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
    Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
    Nuño M; Chowell G; Gumel AB
    J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic.
    Davila-Payan C; Swann J; Wortley PM
    Vaccine; 2014 May; 32(25):3088-93. PubMed ID: 23727421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenza.
    Nishiura H; Iwata K
    Euro Surveill; 2009 Nov; 14(45):. PubMed ID: 19941790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A note on the use of influenza vaccination strategies when supply is limited.
    Lee S; Morales R; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):171-82. PubMed ID: 21361406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the implementation of the H1N1 pandemic influenza vaccine in local health departments (LHDs) in North Carolina.
    DiBiase LM; Davis SE; Rosselli R; Horney J
    Vaccine; 2011 May; 29(23):3969-76. PubMed ID: 21477677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an ongoing epidemic on the annual influenza vaccination rate and vaccination timing among the Medicare elderly: 2000-2005.
    Yoo BK; Kasajima M; Fiscella K; Bennett NM; Phelps CE; Szilagyi PG
    Am J Public Health; 2009 Oct; 99 Suppl 2(Suppl 2):S383-8. PubMed ID: 19797752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States.
    Biggerstaff M; Reed C; Swerdlow DL; Gambhir M; Graitcer S; Finelli L; Borse RH; Rasmussen SA; Meltzer MI; Bridges CB
    Clin Infect Dis; 2015 May; 60 Suppl 1(Suppl 1):S20-9. PubMed ID: 25878298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.